New pill tested in healthy people: first step toward future treatments
NCT ID NCT05110794
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This early-stage trial tested an experimental oral drug called LY3502970 in 34 healthy adults. Researchers measured how much of the drug gets into the blood and how the body processes it, both after eating and on an empty stomach. The main goals were to check safety and understand drug levels, not to treat any disease. The study lasted up to 49 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LY3502970 (an experimental oral drug)
What this could lead to
If successful, this early study will help determine safe dosing for future trials, potentially leading to treatments for conditions like diabetes or obesity.
What could go wrong
This is a very early Phase 1 study in only 34 healthy people. It is designed to check safety and drug levels, not to treat any disease. Many early drugs fail to show benefit in later trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lilly Centre for Clinical Pharmacology
Singapore, 138623, Singapore